Skip to main content
NIH funding notice PAR-14-271

Innovative Therapies and Tools for Screenable Disorders in Newborns (R03)

Closed on September 7, 2017.

Posted
July 2, 2014
Close date
September 7, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $254,367 in first-year total cost, median $84,750.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 GGG-A (50)]1
  2. Special Emphasis Panel[ZRG1 GGG-B (50)]1
  3. Special Emphasis Panel[ZRG1 GGG-Q (51)]1

Most frequent institutions

  1. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  2. TUFTS UNIVERSITY MEDFORD1
  3. UNIVERSITY OF WISCONSIN-MADISON1
Competing awards under PAR-14-271 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Genetic validation of DHTKD1 as a therapeutic target for the treatment of Glutaric Aciduria type 11R03HD092878-01HOUTEN, SANDER MICHELICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$84,750ZRG1
2017Toward Altered Probiotic Therapy for Phenylketonuria1R03HD090444-01NAIR, NIKHIL UNNITUFTS UNIVERSITY MEDFORD, MA$71,910ZRG1
2016Sterol metabolism in Rett syndrome1R03HD086523-01CHANG, QIANGUNIVERSITY OF WISCONSIN-MADISON, WI$97,707ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.